Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?

JN O'Donnell, V Putra, TP Lodise - … : The Journal of Human …, 2021 - Wiley Online Library
This review critically appraises the published microbiologic and clinical data on the
treatment of patients with carbapenem‐resistant Acinetobacter baumannii infections …

Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc …

C Longshaw, A Santerre Henriksen… - Microbiology …, 2023 - Am Soc Microbiol
This study aimed to determine the proportion of heteroresistance in carbapenem-resistant
Acinetobacter calcoaceticus-baumannii complex (CRAB) isolates in the cefiderocol arm of …

Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections

KA Parsels, KA Mastro, JM Steele… - Journal of …, 2021 - academic.oup.com
Cefiderocol is a novel siderophore cephalosporin that forms a complex with extracellular
free ferric iron, which leads to transportation across the outer cell membrane to exert its …

Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene …

PJ Simner, HH Mostafa, Y Bergman… - Clinical Infectious …, 2022 - academic.oup.com
Background As cefiderocol is increasingly being prescribed in clinical practice, it is critical
that we understand key mechanisms contributing to acquired resistance to this agent …

A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft …

X Zhao, H Huang, H Yuan, Z Yuan… - Journal of Antimicrobial …, 2022 - academic.oup.com
Objectives Contezolid is a novel oxazolidinone antibacterial agent for managing infections
caused by aerobic and anaerobic Gram-positive bacteria including methicillin-resistant …

Antibiotic resistance during and beyond COVID-19

DM Livermore - JAC-antimicrobial Resistance, 2021 - academic.oup.com
Antibiotics underpin the 'modern medicine'that has increased life expectancy, leading to
societies with sizeable vulnerable elderly populations who have suffered disproportionately …

Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists

JC Abdul-Mutakabbir, NC Griffith, RK Shields… - Infectious diseases and …, 2021 - Springer
The purpose of this narrative review is to bring together the most recent epidemiologic,
preclinical, and clinical findings to offer our perspective on best practices for managing …

Cefiderocol treatment for patients with multidrug-and carbapenem-resistant Pseudomonas aeruginosa infections in the compassionate use program

MJ Satlin, PJ Simner, CM Slover… - Antimicrobial agents …, 2023 - Am Soc Microbiol
Cefiderocol is an option for infections caused by multidrug-resistant Pseudomonas
aeruginosa, but its in vitro activity against these isolates and its clinical effectiveness for …

Novel antimicrobial agents for gram-negative pathogens

M Karvouniaris, MP Almyroudi, MH Abdul-Aziz, S Blot… - Antibiotics, 2023 - mdpi.com
Gram-negative bacterial resistance to antimicrobials has had an exponential increase at a
global level during the last decades and represent an everyday challenge, especially for the …

Nanomaterials for the diagnosis and treatment of urinary tract infections

M Qindeel, M Barani, A Rahdar, R Arshad… - Nanomaterials, 2021 - mdpi.com
The diagnosis and treatment of urinary tract infections (UTIs) remain challenging due to the
lack of convenient assessment techniques and to the resistance to conventional …